Anti-KCRU/ CKMT1B/ CKMT functional antibody

Anti-KCRU/ CKMT1B/ CKMT functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CKMT1B/CKMT1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1393-Ab-1/ GM-Tg-hg-SE1393-Ab-2Anti-Human CKMT1B monoclonal antibodyHuman
GM-Tg-rg-SE1393-Ab-1/ GM-Tg-rg-SE1393-Ab-2Anti-Rat CKMT1B monoclonal antibodyRat
GM-Tg-mg-SE1393-Ab-1/ GM-Tg-mg-SE1393-Ab-2Anti-Mouse CKMT1B monoclonal antibodyMouse
GM-Tg-cynog-SE1393-Ab-1/ GM-Tg-cynog-SE1393-Ab-2Anti-Cynomolgus/ Rhesus macaque CKMT1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1393-Ab-1/ GM-Tg-felg-SE1393-Ab-2Anti-Feline CKMT1B monoclonal antibodyFeline
GM-Tg-cang-SE1393-Ab-1/ GM-Tg-cang-SE1393-Ab-2Anti-Canine CKMT1B monoclonal antibodyCanine
GM-Tg-bovg-SE1393-Ab-1/ GM-Tg-bovg-SE1393-Ab-2Anti-Bovine CKMT1B monoclonal antibodyBovine
GM-Tg-equg-SE1393-Ab-1/ GM-Tg-equg-SE1393-Ab-2Anti-Equine CKMT1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1393-Ab-1/ GM-Tg-hg-SE1393-Ab-2; GM-Tg-rg-SE1393-Ab-1/ GM-Tg-rg-SE1393-Ab-2;
GM-Tg-mg-SE1393-Ab-1/ GM-Tg-mg-SE1393-Ab-2; GM-Tg-cynog-SE1393-Ab-1/ GM-Tg-cynog-SE1393-Ab-2;
GM-Tg-felg-SE1393-Ab-1/ GM-Tg-felg-SE1393-Ab-2; GM-Tg-cang-SE1393-Ab-1/ GM-Tg-cang-SE1393-Ab-2;
GM-Tg-bovg-SE1393-Ab-1/ GM-Tg-bovg-SE1393-Ab-2; GM-Tg-equg-SE1393-Ab-1/ GM-Tg-equg-SE1393-Ab-2
Products NameAnti-CKMT1B monoclonal antibody
Formatmab
Target NameCKMT1B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CKMT1B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1393-Ag-1Recombinant multi-species KCRU/ CKMT1B/ CKMT protein


    Target information

    Target IDGM-SE1393
    Target NameCKMT1B
    Gene ID1159,12716,29593,101097983
    Gene Symbol and SynonymsCKMT,CKMT1,CKMT1A,CKMT1B,mi-CK,mia-CK,Mt-CK,ScCKmit,U-MtCK,UbCKmit,UMTCK
    Uniprot AccessionP12532,P25809
    Uniprot Entry NameKCRU_HUMAN,KCRU_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000237289
    Target ClassificationN/A

    The target: CKMT1B, gene name: CKMT1B, also named as CKMT, CKMT1, UMTCK. Mitochondrial creatine (MtCK) kinase is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine. It belongs to the creatine kinase isoenzyme family. It exists as two isoenzymes, sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes. Mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes. Many malignant cancers with poor prognosis have shown overexpression of ubiquitous mitochondrial creatine kinase; this may be related to high energy turnover and failure to eliminate cancer cells via apoptosis. Ubiquitous mitochondrial creatine kinase has 80% homology with the coding exons of sarcomeric mitochondrial creatine kinase. Two genes located near each other on chromosome 15 have been identified which encode identical mitochondrial creatine kinase proteins. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.